SmallCapPodcast.com
AGORACOM Small Cap TV AGORACOM Small-Cap Gold and Resources TV Chinese Small Cap Stock TV
LISTEN NOW LISTEN NOW LISTEN NOW
Feb 25, 2020 | by admin | Permalink

Agoracom interviews CEOs of small cap companies.

In this episode of the Small Cap CEO Interviews podcast, AGORACOM speaks with Hollister Biosciences (CSE:HOLL) CEO, Alexander Somjen.

Earlier today, Hollister announced an LOI to acquire Venom Extracts, one of Arizona’s largest producers of Award-Winning Medical Cannabis Distillate. Just how good is Venom? In 2019, Venom generated $CDN 16.4M in revenue and $CDN 2.48M EBITDA in 2019 (subject to due diligence confirmation) … and all of that was just from the state of Arizona! Venom CEO Mason Cave and his team have aggressive plans to expand its brand and success into other states, including California as it benefits from Hollister’s distribution into 220 dispensaries.

If you think “growth talk is cheap” (which is often the case), consider the fact that 30% of Venom’s $20,000,000 sale price kicks in if/when revenues hit $CDN 30,000 and $CDN 40,000 …. by December 31, 2021. In my experience, companies joining forces don’t include such terms if there isn’t a reasonable expectation for hitting those numbers. It doesn’t guarantee it but you can bet they have good reason to believe Venom sales will get to one or both of those numbers in just 21 months from now.

If you’re looking for Cannabis companies that are going to survive and thrive over this next decade, then grab your favourite beverage and watch this interview with Hollinger President, Alex Somjen.

We loved what we heard and look forward to your feedback in Hollister’s CEO Verified Forum below!

Download This Episode

View Company Website

Visit Investor Relations Hub